Related Experiment Video
Updated: Sep 4, 2025

Using a Pan-Viral Microarray Assay Virochip to Screen Clinical Samples for Viral Pathogens
Published on: April 27, 2011
Novel Human Parechovirus 3 Diversity, Recombination, and Clinical Impact Across 7 Years: An Australian Story
Seweryn Bialasiewicz1,2, Meryta May2,3, Sarah Tozer2
1School of Chemistry and Molecular Biosciences, The University of Queensland, Australian Centre for Ecogenomics, St Lucia, Australia.
Background:
A novel human parechovirus 3 Australian recombinant (HPeV3-AR) strain emerged in 2013 and coincided with biennial outbreaks of sepsis-like illnesses in infants. We evaluated the molecular evolution of the HPeV3-AR strain and its association with severe HPeV infections.
Methods:
HPeV3-positive samples collected from hospitalized infants aged 5-252 days in 2 Australian states (2013-2020) and from a community-based birth cohort (2010-2014) were sequenced. Coding regions were used to conduct phylogenetic and evolutionary analyses. A recombinant-specific polymerase chain reaction was designed and utilized to screen all clinical and community HPeV3-positive samples.
Results:
Complete coding regions of 54 cases were obtained, which showed the HPeV3-AR strain progressively evolving, particularly in the 3' end of the nonstructural genes. The HPeV3-AR strain was not detected in the community birth cohort until the initial outbreak in late 2013. High-throughput screening showed that most (>75%) hospitalized HPeV3 cases involved the AR strain in the first 3 clinical outbreaks, with declining prevalence in the 2019-2020 season. The AR strain was not statistically associated with increased clinical severity among hospitalized infants.
Conclusions:
HPeV3-AR was the dominant strain during the study period. Increased hospital admissions may have been from a temporary fitness advantage and/or increased virulence.
Insights
A new human parechovirus 3 Australian recombinant (HPeV3-AR) strain emerged in 2013, causing infant sepsis outbreaks. This study found HPeV3-AR evolved but was not linked to increased infant illness severity.
Area of Science:
- Virology
- Molecular Evolution
- Infectious Diseases
Background:
- A novel human parechovirus 3 Australian recombinant (HPeV3-AR) strain emerged in 2013.
- This emergence coincided with biennial outbreaks of sepsis-like illnesses in infants.
Purpose of the Study:
- To evaluate the molecular evolution of the HPeV3-AR strain.
- To assess the association between the HPeV3-AR strain and severe human parechovirus infections in infants.
Main Methods:
- Sequencing of HPeV3-positive samples from hospitalized infants (2013-2020) and a community birth cohort (2010-2014).
- Phylogenetic and evolutionary analyses of coding regions.
- Development and application of a recombinant-specific PCR for screening.
Main Results:
- The HPeV3-AR strain showed progressive evolution, particularly in nonstructural genes.
- HPeV3-AR was detected in hospitalized infants from late 2013 onwards, dominating early outbreaks.
- The AR strain was not statistically associated with increased clinical severity in hospitalized infants.
Conclusions:
- HPeV3-AR was the dominant strain during the study period.
- Increased hospital admissions may be attributed to a temporary fitness advantage and/or increased virulence of the HPeV3-AR strain.
Related Concept Videos
Viral Recombination
Viral Mutations
Retroviruses
Single Nucleotide Polymorphisms-SNPs
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Retrovirus Life Cycles

